Logo image of COHR

COHERENT CORP (COHR) Stock Fundamental Analysis

NYSE:COHR - New York Stock Exchange, Inc. - US19247G1076 - Common Stock - Currency: USD

90.9  +2.54 (+2.87%)

After market: 90.71 -0.19 (-0.21%)

Fundamental Rating

5

Taking everything into account, COHR scores 5 out of 10 in our fundamental rating. COHR was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and the financial health of COHR get a neutral evaluation. Nothing too spectacular is happening here. COHR is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year COHR was profitable.
COHR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: COHR reported negative net income in multiple years.
Each year in the past 5 years COHR had a positive operating cash flow.
COHR Yearly Net Income VS EBIT VS OCF VS FCFCOHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

COHR has a Return On Assets of -0.22%. This is comparable to the rest of the industry: COHR outperforms 50.40% of its industry peers.
Looking at the Return On Equity, with a value of -0.41%, COHR is in line with its industry, outperforming 51.20% of the companies in the same industry.
With a Return On Invested Capital value of 3.37%, COHR perfoms like the industry average, outperforming 57.60% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for COHR is significantly below the industry average of 9.30%.
The last Return On Invested Capital (3.37%) for COHR is above the 3 year average (2.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.22%
ROE -0.41%
ROIC 3.37%
ROA(3y)-0.92%
ROA(5y)-0.01%
ROE(3y)-1.83%
ROE(5y)-0.48%
ROIC(3y)2.57%
ROIC(5y)2.95%
COHR Yearly ROA, ROE, ROICCOHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

COHR's Operating Margin of 9.86% is fine compared to the rest of the industry. COHR outperforms 80.00% of its industry peers.
In the last couple of years the Operating Margin of COHR has declined.
COHR has a Gross Margin (34.48%) which is comparable to the rest of the industry.
COHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.86%
PM (TTM) N/A
GM 34.48%
OM growth 3Y-33.11%
OM growth 5Y-22.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.56%
GM growth 5Y-4.17%
COHR Yearly Profit, Operating, Gross MarginsCOHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COHR is destroying value.
Compared to 1 year ago, COHR has more shares outstanding
COHR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, COHR has an improved debt to assets ratio.
COHR Yearly Shares OutstandingCOHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
COHR Yearly Total Debt VS Total AssetsCOHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

COHR has an Altman-Z score of 2.04. This is not the best score and indicates that COHR is in the grey zone with still only limited risk for bankruptcy at the moment.
COHR's Altman-Z score of 2.04 is on the low side compared to the rest of the industry. COHR is outperformed by 71.20% of its industry peers.
COHR has a debt to FCF ratio of 14.56. This is a negative value and a sign of low solvency as COHR would need 14.56 years to pay back of all of its debts.
COHR has a Debt to FCF ratio (14.56) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.48 indicates that COHR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.48, COHR is doing worse than 71.20% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 14.56
Altman-Z 2.04
ROIC/WACC0.36
WACC9.36%
COHR Yearly LT Debt VS Equity VS FCFCOHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.47 indicates that COHR has no problem at all paying its short term obligations.
COHR's Current ratio of 2.47 is in line compared to the rest of the industry. COHR outperforms 52.00% of its industry peers.
COHR has a Quick Ratio of 1.54. This is a normal value and indicates that COHR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of COHR (1.54) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 1.54
COHR Yearly Current Assets VS Current LiabilitesCOHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 119.86% over the past year.
COHR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.30% yearly.
Looking at the last year, COHR shows a very strong growth in Revenue. The Revenue has grown by 21.67%.
COHR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.14% yearly.
EPS 1Y (TTM)119.86%
EPS 3Y-23.51%
EPS 5Y-8.3%
EPS Q2Q%71.7%
Revenue 1Y (TTM)21.67%
Revenue growth 3Y14.87%
Revenue growth 5Y28.14%
Sales Q2Q%23.92%

3.2 Future

Based on estimates for the next years, COHR will show a very strong growth in Earnings Per Share. The EPS will grow by 48.77% on average per year.
COHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.04% yearly.
EPS Next Y115.77%
EPS Next 2Y66.12%
EPS Next 3Y48.77%
EPS Next 5YN/A
Revenue Next Year23.87%
Revenue Next 2Y16.6%
Revenue Next 3Y13.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
COHR Yearly Revenue VS EstimatesCOHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
COHR Yearly EPS VS EstimatesCOHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

COHR is valuated quite expensively with a Price/Earnings ratio of 28.32.
Based on the Price/Earnings ratio, COHR is valued a bit cheaper than the industry average as 63.20% of the companies are valued more expensively.
COHR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 19.84 indicates a rather expensive valuation of COHR.
Based on the Price/Forward Earnings ratio, COHR is valued a bit cheaper than 68.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of COHR to the average of the S&P500 Index (21.90), we can say COHR is valued inline with the index average.
Industry RankSector Rank
PE 28.32
Fwd PE 19.84
COHR Price Earnings VS Forward Price EarningsCOHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

COHR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. COHR is cheaper than 69.60% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COHR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 55.14
EV/EBITDA 15.23
COHR Per share dataCOHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COHR's earnings are expected to grow with 48.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y66.12%
EPS Next 3Y48.77%

0

5. Dividend

5.1 Amount

COHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COHERENT CORP

NYSE:COHR (7/3/2025, 7:13:34 PM)

After market: 90.71 -0.19 (-0.21%)

90.9

+2.54 (+2.87%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-13 2025-08-13/amc
Inst Owners92.97%
Inst Owner Change0.44%
Ins Owners0.61%
Ins Owner Change-0.99%
Market Cap14.13B
Analysts81.48
Price Target99.32 (9.26%)
Short Float %4.76%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.23%
Min EPS beat(2)4.19%
Max EPS beat(2)34.28%
EPS beat(4)4
Avg EPS beat(4)14.27%
Min EPS beat(4)0.45%
Max EPS beat(4)34.28%
EPS beat(8)8
Avg EPS beat(8)19.29%
EPS beat(12)11
Avg EPS beat(12)12.37%
EPS beat(16)15
Avg EPS beat(16)11.12%
Revenue beat(2)2
Avg Revenue beat(2)2.12%
Min Revenue beat(2)1.9%
Max Revenue beat(2)2.33%
Revenue beat(4)4
Avg Revenue beat(4)1.44%
Min Revenue beat(4)0.53%
Max Revenue beat(4)2.33%
Revenue beat(8)6
Avg Revenue beat(8)0.91%
Revenue beat(12)7
Avg Revenue beat(12)-0.4%
Revenue beat(16)9
Avg Revenue beat(16)-0.61%
PT rev (1m)3.11%
PT rev (3m)-15.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.01%
EPS NY rev (1m)0.12%
EPS NY rev (3m)1.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.58%
Valuation
Industry RankSector Rank
PE 28.32
Fwd PE 19.84
P/S 2.53
P/FCF 55.14
P/OCF 21.23
P/B 1.81
P/tB 191.7
EV/EBITDA 15.23
EPS(TTM)3.21
EY3.53%
EPS(NY)4.58
Fwd EY5.04%
FCF(TTM)1.65
FCFY1.81%
OCF(TTM)4.28
OCFY4.71%
SpS35.99
BVpS50.27
TBVpS0.47
PEG (NY)0.24
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.41%
ROCE 4.26%
ROIC 3.37%
ROICexc 3.61%
ROICexgc 10.1%
OM 9.86%
PM (TTM) N/A
GM 34.48%
FCFM 4.58%
ROA(3y)-0.92%
ROA(5y)-0.01%
ROE(3y)-1.83%
ROE(5y)-0.48%
ROIC(3y)2.57%
ROIC(5y)2.95%
ROICexc(3y)3.83%
ROICexc(5y)4.17%
ROICexgc(3y)8.28%
ROICexgc(5y)8.58%
ROCE(3y)3.26%
ROCE(5y)3.73%
ROICexcg growth 3Y-38.53%
ROICexcg growth 5Y-25%
ROICexc growth 3Y-46.21%
ROICexc growth 5Y-34.59%
OM growth 3Y-33.11%
OM growth 5Y-22.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.56%
GM growth 5Y-4.17%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 14.56
Debt/EBITDA 3.35
Cap/Depr 72.79%
Cap/Sales 7.32%
Interest Coverage 2
Cash Conversion 59.74%
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 1.54
Altman-Z 2.04
F-Score6
WACC9.36%
ROIC/WACC0.36
Cap/Depr(3y)78.52%
Cap/Depr(5y)70.67%
Cap/Sales(3y)8.43%
Cap/Sales(5y)7.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.86%
EPS 3Y-23.51%
EPS 5Y-8.3%
EPS Q2Q%71.7%
EPS Next Y115.77%
EPS Next 2Y66.12%
EPS Next 3Y48.77%
EPS Next 5YN/A
Revenue 1Y (TTM)21.67%
Revenue growth 3Y14.87%
Revenue growth 5Y28.14%
Sales Q2Q%23.92%
Revenue Next Year23.87%
Revenue Next 2Y16.6%
Revenue Next 3Y13.04%
Revenue Next 5YN/A
EBIT growth 1Y226.98%
EBIT growth 3Y-23.16%
EBIT growth 5Y-0.2%
EBIT Next Year89.64%
EBIT Next 3Y34.79%
EBIT Next 5YN/A
FCF growth 1Y99.42%
FCF growth 3Y-22.55%
FCF growth 5Y36.88%
OCF growth 1Y12.86%
OCF growth 3Y-1.69%
OCF growth 5Y25.05%